Roy Eldor

3.8k citations

70 papers · 2.9k indexed · 1 hit paper · h-index 24

Impact in

Endocrinology, Diabetes and Metabolism top 0.5%
- Diabetes Treatment and Management
- Diabetes Management and Research
Surgery top 2%
- Pancreatic function and diabetes

Papers in ⓘ

Endocrinology, Diabetes and Metabolism 45
- Diabetes Management and Research 33
- Diabetes Treatment and Management 25
- Diabetes, Cardiovascular Risks, and Lipoproteins 7
Surgery 24
- Pancreatic function and diabetes 20

Co-authors: Muhammad Abdul‐Ghani (6 shared papers)Ralph A. DeFronzo (4 shared papers)Itamar Raz (15 shared papers)Giuseppe Daniele (6 shared papers)Devjit Tripathy (4 shared papers)Juan Xiong (4 shared papers)Aurora Merovci (4 shared papers)Luke Norton (4 shared papers)
Journals: Diabetes/Metabolism Research and Reviews (9 papers)Diabetes Obesity and Metabolism (8 papers)Diabetes Care (7 papers)Diabetes (5 papers)Diabetes Research and Clinical Practice (4 papers)
Partner nations: Israel United States United Kingdom

In The Last Decade

Roy Eldor

67 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production 2014 · 635 citations

Peers

Countries citing papers authored by Roy Eldor

Since Specialization

Citations

This map shows the geographic impact of Roy Eldor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Eldor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Eldor more than expected).

Fields of papers citing papers by Roy Eldor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy Eldor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Eldor. The network helps show where Roy Eldor may publish in the future.

Co-authors

The 25 scholars most cited alongside Roy Eldor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roy Eldor Line = papers co-authored together Roy Eldor links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production Journal of Clinical Investigation ·Aurora Merovci, Carolina Solis‐Herrera, Giuseppe Daniele, Roy Eldor, Teresa Vanessa Fiorentino, Devjit Tripathy, Juan Xiong, Zandra Perez, Luke Norton, Muhammad Abdul‐Ghani, Ralph A. DeFronzo Hit paper breakdown →	2014	635
2	Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes Diabetes Care ·Ralph A. DeFronzo, Roy Eldor, Muhammad Abdul‐Ghani	2013	224
3	Conditional and specific NF-κB blockade protects pancreatic beta cells from diabetogenic agents Proceedings of the National Academy of Sciences ·Roy Eldor, Avner Yeffet, Ketty Baum, Victoria Doviner, David Amar, Yinon Ben‐Neriah, Gerhard Christofori, Amnon Peled, Jean‐Claude Carel, Christian Boîtard, Thomas Klein, Palle Serup, Décio L. Eizirik, Danielle Melloul	2006	213
4	Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes Diabetes Care ·Giuseppe Daniele, Juan Xiong, Carolina Solis‐Herrera, Aurora Merovci, Roy Eldor, Devjit Tripathy, Ralph A. DeFronzo, Luke Norton, Muhammad Abdul‐Ghani	2016	167
5	Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage Diabetes/Metabolism Research and Reviews ·Itamar Raz, Roy Eldor, Simona Cernea, Eleazar Shafrir	2004	166
6	Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trial Diabetes Obesity and Metabolism ·Richard E. Pratley, Roy Eldor, Annaswamy Raji, Gregory T. Golm, Susan Huyck, Yanping Qiu, Sheila Sunga, Jeremy Johnson, Steven G. Terra, James P. Mancuso, Samuel S. Engel, Brett Lauring	2017	133
7	Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo‐controlled randomized study Diabetes Obesity and Metabolism ·Samuel Dagogo‐Jack, Jie Liu, Roy Eldor, G. Suárez Amorín, Jeremy Johnson, Darcy A. Hille, Yuqin Liao, Susan Huyck, Gregory T. Golm, Steven G. Terra, James P. Mancuso, Samuel S. Engel, Brett Lauring	2017	123
8	New and experimental approaches to treatment of diabetic foot ulcers: a comprehensive review of emerging treatment strategies Diabetic Medicine ·Roy Eldor, Raz I, A. Ben Yehuda, Andrew J.M. Boulton	2004	96
9	In Vivo Actions of Peroxisome Proliferator–Activated Receptors Diabetes Care ·Roy Eldor, Ralph A. DeFronzo, Muhammad Abdul‐Ghani	2013	95
10	Treatment of new‐onset type 1 diabetes with peptide DiaPep277^® is safe and associated with preserved beta‐cell function: extension of a randomized, double‐blind, phase II trial Diabetes/Metabolism Research and Reviews ·Itamar Raz, Ann Avron, Merana Tamir, Muriel Metzger, L. Symer, Roy Eldor, Irun R. Cohen, Dana Elias	2006	78
11	Glucose-Reducing Effect of the ORMD-0801 Oral Insulin Preparation in Patients with Uncontrolled Type 1 Diabetes: A Pilot Study PLoS ONE ·Roy Eldor, Ehud Arbit, A Corcos, Miriam Kidron	2013	75
12	Glucagonoma and the glucagonoma syndrome - cumulative experience with an elusive endocrine tumour Clinical Endocrinology ·Roy Eldor, Benjamin Gläser, Merav Fraenkel, Victoria Doviner, Asher Salmon, David J. Gross	2011	74
13	Chronic Reduction of Plasma Free Fatty Acid Improves Mitochondrial Function and Whole-Body Insulin Sensitivity in Obese and Type 2 Diabetic Individuals Diabetes ·Giuseppe Daniele, Roy Eldor, Aurora Merovci, Geoffrey D. Clarke, Juan Xiong, Devjit Tripathy, Anna G. Taranova, Muhammad Abdul-Ghani, Ralph A. DeFronzo	2013	62
14	Haemoglobin A1c is a predictor of COVID‐19 severity in patients with diabetes Diabetes/Metabolism Research and Reviews ·Eugene Merzon, Ilan Green, Miriam Shpigelman, Shlomo Vinker, Itamar Raz, Avivit Golan‐Cohen, Roy Eldor	2020	49
15	Type 2 Diabetes Mellitus and Impaired Renal Function Are Associated With Brain Alterations and Poststroke Cognitive Decline Stroke ·Einor Ben Assayag, Roy Eldor, Amos D. Korczyn, Efrat Kliper, Shani Shenhar‐Tsarfaty, Oren Tene, Jeremy Molad, Itzhak Shapira, Shlomo Berliner, Viki Volfson, Ludmila Shopin, Yehuda Strauss, Hen Hallevi, Natan M. Bornstein, Eitan Auriel	2017	46
16	American Diabetes Association Indications for Statins in Diabetes Diabetes Care ·Roy Eldor, Itamar Raz	2009	46
17	Immune modulation for prevention of type 1 diabetes mellitus Trends in biotechnology ·Itamar Raz, Roy Eldor, Yaakov Naparstek	2005	36
18	Lipotoxicity versus adipotoxicity—The deleterious effects of adipose tissue on beta cells in the pathogenesis of type 2 diabetes Diabetes Research and Clinical Practice ·Roy Eldor, Itamar Raz	2006	32
19	Open‐label study to assess the safety and pharmacodynamics of five oral insulin formulations in healthy subjects Diabetes Obesity and Metabolism ·Roy Eldor, Miriam Kidron, Ehud Arbit	2009	29
20	Efficacy and safety of 28‐day treatment with oral insulin ( ORMD ‐0801) in patients with type 2 diabetes: A randomized, placebo‐controlled trial Diabetes Obesity and Metabolism ·Roy Eldor, Joel Neutel, Kenneth Homer, Miriam Kidron	2021	27

About Roy Eldor

Roy Eldor is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Physiology and Genetics, having authored 70 papers that have together received 2.9k indexed citations. Recurring topics across this work include Diabetes Management and Research (33 papers), Diabetes Treatment and Management (25 papers), Pancreatic function and diabetes (20 papers), Metabolism, Diabetes, and Cancer (16 papers), Diabetes and associated disorders (12 papers), Diet and metabolism studies (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Adipose Tissue and Metabolism (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.8k citations), Surgery (1.1k citations), Molecular Biology (1.1k citations), Physiology (405 citations) and Genetics (391 citations). Roy Eldor has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Muhammad Abdul‐Ghani, Ralph A. DeFronzo, Itamar Raz, Giuseppe Daniele, Devjit Tripathy, Juan Xiong, Aurora Merovci, Luke Norton, Carolina Solis‐Herrera and Teresa Vanessa Fiorentino. Their work appears in journals such as Diabetes/Metabolism Research and Reviews, Diabetes Obesity and Metabolism, Diabetes Care, Diabetes and Diabetes Research and Clinical Practice.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact